Connect your AI

BioMarin Pharmaceuticals BMRN Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

RPM InternationalRPM

$6.89M+210%

Southern CompanySO

$1.16B+4.1%

Corvex MOVE

$1.42M—

ImmunityBio, Inc.IBRX

$17.37M-68.7%

MiddlebyMIDD

-$19.2M+4.0%

SiTime CorporationSITM

$71.86M+26.2%

Segments

By segment

Reportable Segment$28.6M-33.6%

Other financials

Income statement

Revenue$766.2M+2.8%

Gross profit$571.2M-3.8%

Operating income$129.6M-42.1%

Net income$105.5M-43.2%

EPS (diluted)$0.54-43.2%

Balance sheet

Cash & equivalents$3.1B+193%

Total debt$1.4B+138%

Total equity$6.2B+7.2%

Total assets$8.6B+20.2%

Cash flow

Operating cash flow$220.7M+26.5%

CapEx$20.9M+24.8%

Free cash flow$199.7M+26.7%

Valuation

Market cap$10.57B-19.4%

Enterprise value$8.93B-29.3%

P/E21.1×-22.7×

P/S3.3×-1.2×

Profitability

Gross margin76.5%-2.9pp

Operating margin19.9%+7.2pp

Net margin16.8%+5.1pp

FCF margin23.7%+2.5pp

Returns & leverage

Return on equity9.1%+2.8pp

Debt / equity0.2×+0.1×

Current ratio5.8×+0.3×